Renal Business Today - Vascular Access

Fresenius Acquires National Vascular Care

WALTHAM, Mass—Fresenius Medical Care’s subsidiary U.S. Vascular Access Holdings has acquired Rosemont, Pa.-based National Vascular Care Inc. ...More

March 5, 2010

Posted in News, Business

Omega-3s and Type 2 Diabetes

In subjects with type 2 diabetes mellitus, six weeks of supplementation with omega–3 fatty acids reduced the postprandial decrease in macrovascular function relative to placebo and improved postprandial microvascular function. ...More

March 4, 2010

Posted in News, Clinical & Pharma

ASDIN Accredits UC Davis Interventional Nephrology Training Program

SACRAMENTO, Calif.—The American Society of Diagnostic and Interventional Nephrology recently accredited UC Davis Health System’s training program in diagnostic interventional nephrology, making it only the second program in California and the 10th in the United States to ...More

February 9, 2010

Posted in News, Clinical & Pharma, Practice Management

Many Hospitals Fail to Reduce Infection Rates Despite Checklists

WASHINGTON—Far too many hospitals fail to lower the rate of deadly central-line bloodstream infections despite the availability of a simple life-saving checklist proven to prevent hospital-acquired infections, according to a new investigative article in the March issue of ...More

February 5, 2010

Posted in News, Business, Clinical & Pharma, Practice Management

Los Angeles Vascular Center Treats 5,000th Patient

The Los Angeles Vascular Center (LAVC) in Inglewood, Calif., announced it treated its 5,000th patient with necessary vascular access care since opening in June 2007. By providing proactive vascular access care and cutting-edge procedures to end-stage renal disease (ESRD) ...More

February 3, 2010

Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management

FDA OKs Pervasis Therapeutics’ Phase 3 Trial of Vascugel®

Pervasis Therapeutics, Inc., reached an agreement with the U.S. Food and Drug Administration (FDA) on the design of a pivotal Phase 3 clinical trial for Vascugel®, an investigational new drug for the prevention of hemodialysis access graft failure. The agreement was made ...More

February 2, 2010

Posted in News, Business, Clinical & Pharma, Government & Regulation

Web Audio Clips Help Monitor Vascular Access Health

MIDLOTHIAN, Va.—The Fistula First Web site has added audio clips of blood flow through arteriovenous (AV) fistulas to help dialysis patients and staff learn what to listen for when monitoring the health of vascular accesses. ...More

January 29, 2010

Posted in News, Business, Clinical & Pharma

Nipro Recalls GlucoPro Insulin Syringes

WASHINGTON—Miami-based Nipro Medical Corporation has initiated a nationwide recall of all GlucoPro Insulin Syringe because they may have needles that detach from the syringe, according to the U.S. Food and Drug Administration. ...More

January 25, 2010

Posted in News, Business, Clinical & Pharma, Government & Regulation

More Research Needed on Kidney Abnormalities, Long-Term Health

Abnormalities in the kidneys and their blood vessels occur in at least 25 percent of healthy individuals, according to a study appearing in the Clinical Journal of the American Society Nephrology (CJASN). While most of these conditions are not harmful enough to prevent ...More

January 14, 2010

Posted in News, Business, Clinical & Pharma

Spire Closes $12.5 Million Catheter Deal with Bard

Spire Corp. said Dec. 16 that it has completed the sale of substantially all of the assets of its hemodialysis catheter business to Bard Access System Inc. ...More

December 18, 2009

Posted in News, Business, Clinical & Pharma

Computers & Software	Consulting, Management...
Equipment & Services	Hemodialysis Supplies
Patient Services	More Options...

Vascular Access

Video Snapshot

Galleries

RBT Poll

Most Popular Articles

Buyer's Guide

Resources

Free Email Updates

featured links

First Name	Last Name
E-Mail